1. Home
  2. REAX vs EMBC Comparison

REAX vs EMBC Comparison

Compare REAX & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REAX
  • EMBC
  • Stock Information
  • Founded
  • REAX 2018
  • EMBC 1924
  • Country
  • REAX United States
  • EMBC United States
  • Employees
  • REAX N/A
  • EMBC N/A
  • Industry
  • REAX
  • EMBC Medical/Dental Instruments
  • Sector
  • REAX
  • EMBC Health Care
  • Exchange
  • REAX Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • REAX 820.5M
  • EMBC 782.5M
  • IPO Year
  • REAX N/A
  • EMBC N/A
  • Fundamental
  • Price
  • REAX $3.60
  • EMBC $14.40
  • Analyst Decision
  • REAX Strong Buy
  • EMBC Buy
  • Analyst Count
  • REAX 3
  • EMBC 2
  • Target Price
  • REAX $6.33
  • EMBC $18.50
  • AVG Volume (30 Days)
  • REAX 1.6M
  • EMBC 329.9K
  • Earning Date
  • REAX 10-30-2025
  • EMBC 11-25-2025
  • Dividend Yield
  • REAX N/A
  • EMBC 4.19%
  • EPS Growth
  • REAX N/A
  • EMBC 18.26
  • EPS
  • REAX N/A
  • EMBC 1.42
  • Revenue
  • REAX $1,813,907,000.00
  • EMBC $1,102,500,000.00
  • Revenue This Year
  • REAX $55.78
  • EMBC N/A
  • Revenue Next Year
  • REAX $22.39
  • EMBC N/A
  • P/E Ratio
  • REAX N/A
  • EMBC $10.07
  • Revenue Growth
  • REAX 65.60
  • EMBC N/A
  • 52 Week Low
  • REAX $3.42
  • EMBC $9.20
  • 52 Week High
  • REAX $5.65
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • REAX 41.67
  • EMBC 56.32
  • Support Level
  • REAX $3.60
  • EMBC $14.07
  • Resistance Level
  • REAX $4.16
  • EMBC $14.91
  • Average True Range (ATR)
  • REAX 0.21
  • EMBC 0.53
  • MACD
  • REAX 0.03
  • EMBC 0.10
  • Stochastic Oscillator
  • REAX 27.89
  • EMBC 72.34

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: